SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership [amend]
SEC Accession No. 0000899140-06-001325
Filing Date
2006-09-14
Accepted
2006-09-14 11:53:10
Documents
2
Filing Date Changed
2006-09-14
Group Members
DANIEL S. LOEBTHIRD POINT OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 FIFTH AMENDMENT t091406b.txt SC 13D/A 15115
3 LETTER TO BOARD OF DIRECTORS t091406c.txt EX-99.1 17720
  Complete submission text file 0000899140-06-001325.txt   35213
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 061089965
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A